跳至主要内容
临床试验/NCT06650293
NCT06650293已完成不适用

Effect of Vitamin D Supplementation as Adjuvant Therapy in Neonatal Jaundice in Combination With Phototherapy

Muhammad Aamir Latif1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年5月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Total Serum bilirubin levels

研究概览

简要总结

Neonatal jaundice frequently occur during initial week of life. Neonatal jaundice is one of the leading causes of hospital admission and readmission. Some studies have suggested that the healthy newborns with hyperbilirubinemia outside the physiological range have notably reduced serum vitamin D levels. This deficiency is inversely associated with neonatal hyperbilirubinemia, suggesting that low vitamin D levels could be a potential risk factor for jaundice among neonates.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Days 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Both genders
  • Admitted between 3-28 days of age.
  • Indirect hyperbilirubinemia with TSB levels between 14-20 mg/dL
  • Born via either cesarean or vaginal delivery
  • Birth weight greater than 2500 grams

排除标准

  • Prior phototherapy treatment
  • Preterm birth (gestational age below 37 weeks).
  • SpO2 < 95% at the time of admission
  • Severe respiratory distress or failure
  • Neonatal sepsis
  • Congenital anomalies
  • Parents/guardians unwilling to let their neonates be part of this study.

研究组 & 干预措施

Group-A

Experimental

Neonates receive phototherapy plus vitamin D

干预措施: Vitamin D (Drug)

结局指标

主要结局

Total Serum bilirubin levels

时间窗: 5 days

Total Serum bilirubin levels evaluated

次要结局

未报告次要终点

研究者

发起方
Muhammad Aamir Latif
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Muhammad Aamir Latif

Research Consultant

RESnTEC, Institute of Research

研究点 (1)

Loading locations...

相似试验